San Diego, CA, United States of America

Gerard T Hardiman

USPTO Granted Patents = 10 


Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 53(Granted Patents)


Location History:

  • Mountain View, CA (US) (2003)
  • San Diego, CA (US) (2003 - 2013)

Company Filing History:


Years Active: 2003-2013

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Gerard T. Hardiman

Introduction

Gerard T. Hardiman is a notable inventor based in San Diego, CA. He has made significant contributions to the field of chemokines, holding a total of 10 patents. His work focuses on the development of methods and reagents related to CX3C chemokines, which play a crucial role in various biological processes.

Latest Patents

Among his latest patents, Gerard has developed a method for blocking the binding of CX3C chemokines using specific antibodies. This patent describes nucleic acids encoding a new family of chemokines, the CX3C family, from mammals. It also includes reagents related to these chemokines, such as specific antibodies and purified proteins. Additionally, he has patented mouse CX3C chemokine polypeptides, which also involve nucleic acids and related diagnostic kits.

Career Highlights

Gerard T. Hardiman has had a distinguished career, working at Schering Corporation, where he has been able to apply his expertise in chemokine research. His innovative approaches have led to advancements in understanding and utilizing chemokines in various applications.

Collaborations

Throughout his career, Gerard has collaborated with esteemed colleagues, including Devora L. Rossi and Albert Zlotnik. These collaborations have further enriched his research and contributed to the success of his projects.

Conclusion

Gerard T. Hardiman's contributions to the field of chemokines and his numerous patents highlight his role as a leading inventor in this area. His work continues to influence research and development in the biomedical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…